戈舍瑞林联合曼月乐治疗子宫腺肌病的效果评价
本文关键词:戈舍瑞林联合曼月乐治疗子宫腺肌病的效果评价 出处:《中国当代医药》2016年34期 论文类型:期刊论文
【摘要】:目的探讨戈舍瑞林联合曼月乐治疗子宫腺肌病的效果。方法将2014年2月~2015年2月在我院妇科治疗的70例子宫腺肌病患者随机分为观察组和对照组,每组各37例。对照组单用戈舍瑞林治疗,观察组采用戈舍瑞林联合曼月乐治疗。比较两组患者的治疗效果、子宫各项指标、痛经及月经改善情况;观察两组的不良反应。结果观察组治疗有效率为94.29%,显著高于对照组的85.71%,差异有统计学意义(P0.05);观察组治疗后子宫体积及子宫内膜厚度均明显小于对照组,差异有统计学意义(P0.05);观察组治疗后痛经程度评分及PBAC月经量评分均明显低于对照组,差异有统计学意义(P0.05);两组疲乏、骨痛、更年期症状、烦躁、阴道不规则流血、乳房胀痛等不良反应的总发生率比较差异无统计学意义(P0.05)。结论戈舍瑞林联合曼月乐治疗子宫腺肌病的效果显著,能够直接作用于子宫病灶,抑制子宫内膜的异常生长,减轻病灶活性,改善临床症状,有效避免了手术治疗,具有积极的临床意义。
[Abstract]:Objective to investigate the efficacy of goserelin combined with manyue in the treatment of adenomyosis. Methods 70 cases of adenomyosis treated in our hospital from February 2014 to February 2015 were randomly divided into observation group and control group. Group. There were 37 cases in each group. The control group was treated with goserelin alone, while the observation group was treated with goserelin combined with manyue. The therapeutic effect, uterine parameters, dysmenorrhea and menstrual improvement were compared between the two groups. Results the effective rate of treatment in the observation group was 94.29, which was significantly higher than that in the control group (85.71, P 0.05). The volume of uterus and the thickness of endometrium in the observation group were significantly lower than those in the control group after treatment, and the difference was statistically significant (P 0.05). After treatment, the scores of dysmenorrhea and PBAC menstrual volume in the observation group were significantly lower than those in the control group (P 0.05). Fatigue, bone pain, menopausal symptoms, irritability, irregular vaginal bleeding. There was no significant difference in the total incidence of adverse reactions such as breast distension and pain. Conclusion Gosherrelin combined with Manyuelo is effective in the treatment of adenomyosis and can directly affect uterine lesions. It has positive clinical significance to inhibit abnormal growth of endometrium, reduce focus activity, improve clinical symptoms and avoid surgical treatment.
【作者单位】: 广东省惠东县妇幼保健院妇科;
【分类号】:R711.71
【正文快照】: 子宫腺肌病为临床育龄期妇女常见疾病,是指在多种因素的刺激下,子宫内膜腺体和间质侵入子宫肌层,造成弥漫性病变。本病呈进行性加重,临床表现为痛经、月经过多、贫血、性交痛等,B超检查可见子宫增大,严重者甚至发生不孕,影响正常生活和心理健康[1]。本病的治疗手段较多,其治疗
【相似文献】
相关期刊论文 前10条
1 赵燕茹;;戈舍瑞林对卵巢子宫内膜异位症术后治疗的分析[J];中国社区医师(医学专业半月刊);2009年24期
2 庄惠娜;李林娜;余燕学;;醋酸戈舍瑞林缓释植入剂治疗内异症的临床研究[J];临床医学工程;2013年01期
3 魏开敏;戈舍瑞林的妇科疾病用途[J];家庭医学;1998年19期
4 杨双;曾改鸿;林晓华;;腹腔镜术后联合戈舍瑞林治疗盆腔子宫内膜异位症所致不孕105例疗效观察[J];中国妇幼保健;2009年31期
5 谭先杰,郎景和;戈舍瑞林在妇科疾病中应用的疗效及安全性[J];中华妇产科杂志;1998年01期
6 高娟;;腹腔镜配合戈舍瑞林治疗卵巢子宫内膜异位症68例[J];中华妇幼临床医学杂志(电子版);2012年03期
7 李鹤成;戈舍瑞林用于乳腺癌治疗的研究进展[J];国外医学(肿瘤学分册);2002年02期
8 徐庆春;张永海;李湖;黄洪;曾绍文;周文虹;;戈舍瑞林对减少经尿道前列腺切除术中出血的机制研究[J];现代泌尿外科杂志;2011年04期
9 张枢;韩江彬;冷广意;沙春洁;刘万卉;;戈舍瑞林缓释植入剂在大鼠体内的药代动力学及药效动力学[J];中国药理学与毒理学杂志;2014年03期
10 何海飞,邓甬川;戈舍瑞林用于绝经前早期乳腺癌研究进展[J];国外医学(肿瘤学分册);2005年08期
相关重要报纸文章 前2条
1 闻声;戈舍瑞林可降低乳癌复发风险[N];中国医药报;2007年
2 李菊香;戈舍瑞林可延长前列腺癌患者生命[N];中国医药报;2005年
相关硕士学位论文 前3条
1 刘艳佳;子宫内膜不典型增生药物治疗效果分析[D];新疆医科大学;2015年
2 宋扬;戈舍瑞林的液相合成研究[D];天津大学;2010年
3 赵晓燕;戈舍瑞林对绝经前乳腺癌化疗期间卵巢功能影响的研究[D];郑州大学;2012年
,本文编号:1378386
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1378386.html